Gladstone NOW: The Campaign Join Us on the Journey ✕
496 - 510 of 1428 Results Clear All
Brain Injury Radio—On a radio show dedicated to traumatic brain injury (TBI), Associate Investigator Jeanne Paz, PhD, explains her life-long interest and current work in TBI and in epilepsy, a common long-term consequence of brain damage.
Gladstone Experts Traumatic Brain Injury Epilepsy Paz Lab
San Francisco Chronicle—The emerging Omicron variant of SARS-CoV-2 features several mutations in its spike protein that in theory could make it resistant to current vaccines. But Associate Investigator Nadia Roan, PhD, explains that current vaccines will still protect against Omicron, as they elicit a variety of antibodies and immune T cells that target non-mutated areas of spike.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
ABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Krogan Lab Srivastava Lab
Watch recordings from the Gladstone-UCSF Institute of Genomic Immunology Symposium
Gladstone Experts Genomic Immunology Marson Lab Pelka Lab Genomics
NIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.
Gladstone Experts COVID-19 Infectious Disease Doudna Lab Ott Lab
BioIT World—Despite decades of research, medical therapies for Alzheimer’s disease have so far proven elusive. Senior Investigator Yadong Huang describes how his innovative approach to drug repurposing has identified a promising candidate drug that is now moving toward clinical trials.
Gladstone Experts Alzheimer’s Disease Neurological Disease Huang Lab
Vijay Ramani, who develops novel tools to study single molecules, joins Gladstone Institutes
Institutional News News Release Profile Data Science and Biotechnology Ramani Lab
ABC News—Traumatic brain injuries can result in sleep disruptions and seizures. Gladstone Associate Investigator Jeanne Paz describes her team’s recent identification of an immune molecule that may be key to these symptoms, and the potential to treat brain injury survivors with new therapies.
Gladstone Experts Traumatic Brain Injury Neurological Disease Paz Lab
Using virus-like particles, researchers find an unexpected explanation for why some coronavirus variants spread faster
Research (Publication) Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab
Nautilus—In the ongoing war on cancer, some scientists are taking a new approach—turning on the body’s own self defense system. Assistant Investigator Karin Pelka describes her team’s efforts to train the immune system to recognize and fight tumors.
Gladstone Experts Genomic Immunology Pelka Lab
Scientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.
Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, puts the CDC's definition of "fully vaccinated" in the context of our constantly evolving understanding of the COVID-19 pandemic.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
Gladstone scientists identified treatments to block subtle epileptic activity and chronic brain inflammation in a mouse model of Alzheimer’s disease
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab
Gladstone virologists discuss the state of the pandemic and how to stay safe this holiday season
COVID-19 Greene Lab Ott Lab
